北京大学学报(医学版) ›› 2024, Vol. 56 ›› Issue (5): 928-931. doi: 10.19723/j.issn.1671-167X.2024.05.028

• 病例报告 • 上一篇    下一篇

类风湿关节炎伴发淋巴结Castleman样病理改变1例

刘东武1, 陈杰2, 高明利1, 于静1,*()   

  1. 1. 辽宁中医药大学附属医院风湿免疫科,沈阳 110032
    2. 辽宁中医药大学中西医结合学院,沈阳 110847
  • 收稿日期:2021-08-15 出版日期:2024-10-18 发布日期:2024-10-16
  • 通讯作者: 于静 E-mail:yujingliaoning@163.com

Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report

Dongwu LIU1, Jie CHEN2, Mingli GAO1, Jing YU1,*()   

  1. 1. Department of Rheumatology and Immunology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China
    2. College of Integrative Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, China
  • Received:2021-08-15 Online:2024-10-18 Published:2024-10-16
  • Contact: Jing YU E-mail:yujingliaoning@163.com

RICH HTML

  

关键词: 类风湿关节炎, Castleman样病理改变, 淋巴结肿大

Abstract:

Rheumatoid arthritis (RA) is a common chronic autoimmune inflammatory disease, characterized by persistent polyarthritis. Patients with RA may exhibit varying degrees of B lymphocyte activation, clinically manifested as enlarged lymph nodes. Disease-modifying anti-rheumatic drugs and glucocorticoid are often used to treat RA. Biological agents targeting tumor necrosis factor alpha, interleukin-6(IL-6), and B lymphocytes are often used to treat rheumatoid arthritis. Castleman disease (CD) is a rare benign lymphoproliferative disorder. Histopathological examination is the most important method to diagnose this disease. Based on the different lymph node involvement areas CD can be divided into unicentric CD(UCD) and multicentric CD(MCD). Surgical removal of lymph nodes is a common treatment method for UCD. MCD often requires chemotherapeutic drugs combined with glucocorticoid therapy. For the most recent years, biological agents targeting IL-6 and B lymphocytes have shown good curative effects on CD. In the past, patients with rheumatic immune disease accompanied by Castleman like histopathology in lymph nodes were commonly referred to as rheumatic immune disease combined with CD. In 2021, experts unanimously agreed that autoimmune diseases with Castleman like lymphadenopathy should be diagnosed as rheumatic autoimmune diseases with Castleman like histopathology in lymph nodes. This report introduces a 65-year-old female patient with rheumatoid arthritis who was admitted to the hospital due to joint swelling and pain. Physical and chemical examinations after admission showed that rheumatoid arthritis was in an active phase. Chest CT revealed multiple enlarged lymph nodes in the right armpit. Then it was removed by surgery. The histopathological report showed that the lymphatic sinus disappeared, the lymphoid tissue proliferated, the lymphoid follicles increased, and the size was inconsistent. The small lymphocytes around the germinal centers of some follicles were concentric circles, and the follicular interstitial blood vessels proliferated. She was diagnosed with rheumatoid arthritis with Castleman like histopathology in lymph nodes and was treated with methotrexate and hydroxychloroquine sulfate combined with glucocorticoids. The patient was followed up for 2 years. In the first year after sur-gery, the patient' s condition remained stable and there was no growth of lymph nodes in the right axilla. The patient passed away due to severe infection in the second year after the surgery.

Key words: Rheumatoid arthritis, Castleman like histopathology, Enlarged lymph nodes

中图分类号: 

  • R593.2

图1

患者胸部CT及淋巴结病理"

1 Demirkan FG , Doǧan S , Kalyoncu Uçar A , et al. Systemic lupus erythematosus complicated with Castleman disease: A case-based review[J]. Rheumatol Int, 2021, 41 (2): 475- 479.
doi: 10.1007/s00296-020-04684-4
2 Minemura H , Tanino Y , Ikeda K . Possible association of multicentric Castleman' s disease with autoimmune lymphoproliferative syndrome[J]. Biores Open Access, 2018, 7 (1): 47- 51.
doi: 10.1089/biores.2017.0025
3 Tabata S , Higuchi T , Tatsukawa S , et al. Idiopathic multicentric Castleman disease with autoimmune hemolytic anemia and production of anti-drug antibody against tocilizumab[J]. Intern Med, 2019, 58 (22): 3313- 3318.
doi: 10.2169/internalmedicine.2989-19
4 中华医学会血液学分会淋巴细胞疾病学组, 中国抗癌协会血液肿瘤专业委员会, 中国Castleman病协作组. 中国Castleman病诊断与治疗专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42 (7): 529- 534.
5 郑东辉, 莫颖倩, 戴冽, 等. 类风湿关节炎不同滑膜淋巴细胞分布类型的临床病理特点[J]. 中山大学学报(医学科学版), 2009, 30 (5): 571- 576.
6 张玲玲, 魏伟. BAFF/BAFF-R通过PI3K/Akt/mTOR信号转导通路调节B淋巴细胞功能在类风湿关节炎发病机制中的意义[J]. 中国药理学通报, 2010, 26 (7): 847- 850.
7 Picemo V , Ferro F , Adinolfi A , et al. One year in riview: The pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2015, 33 (4): 551- 558.
8 唐果, 龙丽, 韩雅欣, 等. 类风湿关节炎合并结核感染的临床特点及相关因素[J]. 北京大学学报(医学版), 2020, 52 (6): 1029- 1033.
9 刘娣, 郭万珍, 蔡华聪, 等. 类风湿关节炎并发淋巴瘤的临床特征[J]. 中华临床免疫和变态反应杂志, 2015, 9 (4): 292- 296.
10 Castleman B , Towne V . Case records of the Massachusetts General Hospital weekly clinicopathological exercises: Case 40011[J]. N Engl J Med, 1954, 250 (1): 26- 30.
doi: 10.1056/NEJM195401072500107
11 Wang HW , Pittaluga S , Jaffe ES . Multicentric Castleman disease: Where are we now?[J]. Semin Diagn Pathol, 2016, 33 (5): 294- 306.
doi: 10.1053/j.semdp.2016.05.006
12 Nguyen D , Diamond L , Hansmann N , et al. Castleman' s disease. Differences in follicular dendritic network in the hyaline vascular and plasma cell variants[J]. Histopathology, 1994, 24 (5): 437- 443.
doi: 10.1111/j.1365-2559.1994.tb00552.x
13 Herrada J , Cabanillas F , Rice L , et al. The clinical behavior of localized and multicentric Castleman disease[J]. Ann Intern Med, 1998, 128 (8): 657- 662.
doi: 10.7326/0003-4819-128-8-199804150-00010
14 Peterson B , Frizzera G . Multicentric Castleman' s disease[J]. Semin Oncol, 1993, 20 (6): 636- 647.
15 Frizzera G , Peterson BA , Bayrd ED , et al. A systemic lymphoproliferative disorder with morphologic features of Castleman' s disease: Clinical findings and clinicopathologic correlations in 15 patients[J]. J Clin Oncol, 1985, 3 (9): 1202- 1216.
doi: 10.1200/JCO.1985.3.9.1202
16 Bowne WB , Lewis JJ , Filippa DA , et al. The management of unicentric and multicentric Castleman' s disease: A report of 16 cases and a review of the literature[J]. Cancer, 1999, 85 (3): 706- 717.
doi: 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7
17 Nishimoto N , Kanakura Y , Aozasa K , et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease[J]. Blood, 2005, 106 (8): 2627- 2632.
doi: 10.1182/blood-2004-12-4602
18 Casper C , Voorhees PM , Fayad LE , et al. An open-label, phase 2, multicenter study of the safety of long-term treatment with siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman' s disease[J]. Blood, 2013, 122 (21): 1806.
doi: 10.1182/blood.V122.21.1806.1806
19 de Marchi G , de Vita S , Fabris M , et al. Systemic connective tissue disease complicated by Castleman' s disease: Report of a case and review of the literature[J]. Haematologica, 2004, 89 (4): 7- 10.
20 Jacobs SA , Vidnovic N , Patel H , et al. Durable remission of HIV-negative, Kaposi' s sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate[J]. Clin Rheumatol, 2007, 26 (7): 1148- 1150.
doi: 10.1007/s10067-006-0272-8
21 Sun Y , Wang D , Salvadore G , et al. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castle-man' s disease[J]. Brain Behav Immun, 2017, 66 (11): 156- 164.
[1] 黄会娜,赵静,赵祥格,白自然,李霞,王冠. 乳酸对类风湿关节炎患者外周血CD4+T细胞亚群的调控作用[J]. 北京大学学报(医学版), 2024, 56(3): 519-525.
[2] 汤晓菲,李永红,丁秋玲,孙卓,张阳,王育梅,田美伊,刘坚. 类风湿关节炎患者下肢深静脉血栓发病率及危险因素[J]. 北京大学学报(医学版), 2024, 56(2): 279-283.
[3] 邹雪,白小娟,张丽卿. 艾拉莫德联合托法替布治疗难治性中重度类风湿关节炎的疗效[J]. 北京大学学报(医学版), 2023, 55(6): 1013-1021.
[4] 吴琦,蔡月明,何娟,黄文蒂,王庆文. 血脂异常与类风湿关节炎肺间质病变的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 982-992.
[5] 张警丰,金银姬,魏慧,姚中强,赵金霞. 体重指数与类风湿关节炎临床特征的相关性分析[J]. 北京大学学报(医学版), 2023, 55(6): 993-999.
[6] 金银姬,孙琳,赵金霞,刘湘源. 血清IgA型抗鼠科肉瘤病毒癌基因同源物B1抗体在类风湿关节炎中的意义[J]. 北京大学学报(医学版), 2023, 55(4): 631-635.
[7] 蔡文心,李仕成,刘一鸣,梁如玉,李静,郭建萍,胡凡磊,孙晓麟,李春,刘栩,叶华,邓立宗,李茹,栗占国. 类风湿关节炎临床分层及其特征的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1068-1073.
[8] 程昉,杨邵英,房星星,王璇,赵福涛. CCL28-CCR10通路在类风湿关节炎单核细胞迁移中的作用[J]. 北京大学学报(医学版), 2022, 54(6): 1074-1078.
[9] 刘蕊,赵金霞,闫良. 类风湿关节炎合并下肢静脉血栓患者的临床特点[J]. 北京大学学报(医学版), 2022, 54(6): 1079-1085.
[10] 张警丰,金银姬,魏慧,姚中强,赵金霞. 类风湿关节炎患者生活质量与疾病活动度的横断面研究[J]. 北京大学学报(医学版), 2022, 54(6): 1086-1093.
[11] 高超,陈立红,王莉,姚鸿,黄晓玮,贾语博,刘田. 类风湿关节炎合并纤维肌痛简易分类标准的临床验证[J]. 北京大学学报(医学版), 2022, 54(2): 278-282.
[12] 娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健. 类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达[J]. 北京大学学报(医学版), 2021, 53(6): 1020-1025.
[13] 钟华,徐丽玲,白明欣,苏茵. 类风湿关节炎患者趋化因子CXCL9和CXCL10在骨侵蚀中的作用[J]. 北京大学学报(医学版), 2021, 53(6): 1026-1031.
[14] 罗靓,霍文岗,张钦,李春. 类风湿关节炎合并角膜溃疡的临床特点和相关因素分析[J]. 北京大学学报(医学版), 2021, 53(6): 1032-1036.
[15] 张璐,胡小红,陈澄,蔡月明,王庆文,赵金霞. 类风湿关节炎初治患者颈椎失稳情况及临床特征[J]. 北京大学学报(医学版), 2021, 53(6): 1049-1054.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!